- £199.64m
- £193.10m
- £57.63m
- 89
- 12
- 98
- 78
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 21.57 | ||
| PEG Ratio (f) | 0.97 | ||
| EPS Growth (f) | 28.44% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.65 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 43.87 | ||
| Price to Sales | 3.31 | ||
| EV to EBITDA | 20.57 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 9.13% | ||
| Return on Equity | 6.45% | ||
| Operating Margin | 8.79% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 22.7 | 25.72 | 28.22 | 46.02 | 57.63 | 65 | 73.4 | 22.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +100.33 | -28.65 | +74.11 | -36.9 | +154.06 | +34.59 | +27.83 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Instem plc is a United Kingdom-based company that is a provider of information technology (IT) solutions to the global life sciences market. The Company operates through four segments: Study Management, Regulatory Solutions, In Silico Solutions and Clinical Trial Acceleration. Study Management Solutions offers software that enables organizations to collect, review, manage and report discovery and preclinical data. Regulatory Solutions provides software, outsourced services and consulting for managing, storing, sharing, submitting and maintaining information compliant with agency regulations. The Company's In Silico Solutions enable researchers to generate scientific insights through the identification, extraction and analysis of information. Clinical Trials Acceleration Solutions offers technology solutions and consulting services to facilitate data integration, statistics, analytics and insights for companies of any size or stage of clinical trial analysis.
Directors
- David Gare NEC
- Philip Reason CEO
- Nigel Goldsmith CFO
- David Sherwin NED
- Riaz Bandali NID (52)
- Michael McGoun NID (72)
- Last Annual
- December 31st, 2022
- Last Interim
- June 30th, 2023
- Incorporated
- February 5th, 2010
- Public Since
- October 13th, 2010
- No. of Employees
- 493
- Sector
- Software & IT Services
- Industry
- Technology
- Exchange
London Stock Exchange- Shares in Issue
- 24,053,390
- Address
- Diamond Way, Stone Business Park, STONE, ST15 0SD
- Web
- https://www.instem.com/
- Phone
- +44 1785825600
- Contact
- Tom Cooper
- Auditors
- PKF Littlejohn LLP
Latest News for INS
Upcoming Events for INS
Full Year 2023 Instem PLC Earnings Release
Similar to INS
1Spatial
London Stock Exchange
4Global
London Stock Exchange
Access Intelligence
London Stock Exchange
accesso Technology
London Stock Exchange
Activeops
London Stock Exchange
FAQ
As of Today at 18:11 UTC, shares in Instem are trading at 830.00p. This share price information is delayed by 15 minutes.
Shares in Instem last closed at 830.00p and the price had moved by +22.06% over the past 365 days. In terms of relative price strength the Instem share price has outperformed the FTSE All Share Index by +21.12% over the past year.
The overall consensus recommendation for Instem is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreInstem does not currently pay a dividend.
Instem does not currently pay a dividend.
Instem does not currently pay a dividend.
To buy shares in Instem you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 830.00p, shares in Instem had a market capitalisation of £199.64m.
Here are the trading details for Instem:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: INS
Based on an overall assessment of its quality, value and momentum Instem is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Instem is 1,023.00p. That is 23.25% above the last closing price of 830.00p.
Analysts covering Instem currently have a consensus Earnings Per Share (EPS) forecast of £0.31 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Instem. Over the past six months, its share price has outperformed the FTSE All Share Index by +34.32%.
As of the last closing price of 830.00p, shares in Instem were trading +21.71% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Instem PE ratio based on its reported earnings over the past 12 months is 21.57. The shares last closed at 830.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Instem's management team is headed by:
- David Gare - NEC
- Philip Reason - CEO
- Nigel Goldsmith - CFO
- David Sherwin - NED
- Riaz Bandali - NID
- Michael McGoun - NID